Smith‐Magenis syndrome: Clinical and behavioral characteristics in a large retrospective cohort. Issue 4 (5th January 2021)
- Record Type:
- Journal Article
- Title:
- Smith‐Magenis syndrome: Clinical and behavioral characteristics in a large retrospective cohort. Issue 4 (5th January 2021)
- Main Title:
- Smith‐Magenis syndrome: Clinical and behavioral characteristics in a large retrospective cohort
- Authors:
- Rive Le Gouard, Nicolas
Jacquinet, Adeline
Ruaud, Lyse
Deleersnyder, Hélène
Ageorges, Faustine
Gallard, Jennifer
Lacombe, Didier
Odent, Sylvie
Mikaty, Myriam
Manouvrier‐Hanu, Sylvie
Ghoumid, Jamal
Geneviève, David
Lehman, Natacha
Philip, Nicole
Edery, Patrick
Héron, Delphine
Rastel, Coralie
Chancenotte, Sophie
Thauvin‐Robinet, Christel
Faivre, Laurence
Perrin, Laurence
Verloes, Alain - Abstract:
- Abstract: Smith‐Magenis syndrome (SMS), characterized by dysmorphic features, neurodevelopmental disorder, and sleep disturbance, is due to an interstitial deletion of chromosome 17p11.2 (90%) or to point mutations in the RAI1 gene. In this retrospective cohort, we studied the clinical, cognitive, and behavioral profile of 47 European patients with SMS caused by a 17p11.2 deletion. We update the clinical and neurobehavioral profile of SMS. Intrauterine growth was normal in most patients. Prenatal anomalies were reported in 15%. 60% of our patients older than 10 years were overweight. Prevalence of heart defects (6.5% tetralogy of Fallot, 6.5% pulmonary stenosis), ophthalmological problems (89%), scoliosis (43%), or deafness (32%) were consistent with previous reports. Epilepsy was uncommon (2%). We identified a high prevalence of obstipation (45%). All patients had learning difficulties and developmental delay, but ID range was wide and 10% of patients had IQ in the normal range. Behavioral problems included temper tantrums and other difficult behaviors (84%) and night‐time awakenings (86%). Optimal care of SMS children is multidisciplinary and requires important parental involvement. In our series, half of patients were able to follow adapted schooling, but 70% of parents had to adapt their working time, illustrating the medical, social, educative, and familial impact of having a child with SMS. Abstract : Smith‐Magenis Syndrome (SMS) is a rare disease due to either a smallAbstract: Smith‐Magenis syndrome (SMS), characterized by dysmorphic features, neurodevelopmental disorder, and sleep disturbance, is due to an interstitial deletion of chromosome 17p11.2 (90%) or to point mutations in the RAI1 gene. In this retrospective cohort, we studied the clinical, cognitive, and behavioral profile of 47 European patients with SMS caused by a 17p11.2 deletion. We update the clinical and neurobehavioral profile of SMS. Intrauterine growth was normal in most patients. Prenatal anomalies were reported in 15%. 60% of our patients older than 10 years were overweight. Prevalence of heart defects (6.5% tetralogy of Fallot, 6.5% pulmonary stenosis), ophthalmological problems (89%), scoliosis (43%), or deafness (32%) were consistent with previous reports. Epilepsy was uncommon (2%). We identified a high prevalence of obstipation (45%). All patients had learning difficulties and developmental delay, but ID range was wide and 10% of patients had IQ in the normal range. Behavioral problems included temper tantrums and other difficult behaviors (84%) and night‐time awakenings (86%). Optimal care of SMS children is multidisciplinary and requires important parental involvement. In our series, half of patients were able to follow adapted schooling, but 70% of parents had to adapt their working time, illustrating the medical, social, educative, and familial impact of having a child with SMS. Abstract : Smith‐Magenis Syndrome (SMS) is a rare disease due to either a small loss in the chromosome 17 or a mutation in a specific gene at the same location. This neurodevelopmental disorder is characterized by learning and intellectual disabilities, behavioral disorder and a specific sleep disturbance with an inversion of the day‐night cycle. Here, we report an important number of SMS patients and thus provide a better support for patients and families. … (more)
- Is Part Of:
- Clinical genetics. Volume 99:Issue 4(2021)
- Journal:
- Clinical genetics
- Issue:
- Volume 99:Issue 4(2021)
- Issue Display:
- Volume 99, Issue 4 (2021)
- Year:
- 2021
- Volume:
- 99
- Issue:
- 4
- Issue Sort Value:
- 2021-0099-0004-0000
- Page Start:
- 519
- Page End:
- 528
- Publication Date:
- 2021-01-05
- Subjects:
- 17p11.2 -- clinical characteristics -- neurodevelopmental disorder -- obstipation -- Smith‐Magenis -- social impact
Medical genetics -- Periodicals
616.0420 - Journal URLs:
- http://www.blackwell-synergy.com/loi/cge ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cge.13906 ↗
- Languages:
- English
- ISSNs:
- 0009-9163
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.287000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 17399.xml